OrthoPediatrics prelim Q4 revenue $37.6M (+21%); acquires Boston O&P; 2024 guidance $197-200M

ORTHOPEDIATRICS CORP

2023-FY EPS reported -$0.92 revenue$148,732,000

Preliminary Q4 2023 net revenue $37.6M (up 21% YoY); full year $148.7M (up 22%).
Domestic Q4 rev $28.3M (+24%), int'l $9.3M (+13%). FY domestic $111.0M (+20%), int'l $37.7M (+26%).
Acquired Boston O&P on Jan 5, 2024 (annual revenue ~$25M); deal expected accretive to adjusted EBITDA in 2024.
2024 revenue guidance $197M-$200M (32-34% growth). Cash ~$60M post-acquisition; new $30M term + $50M revolver.
Acquisition of Boston O&P was also a customer/supplier; Q4 helped ~20k kids, cumulative >710k.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ORTHOPEDIATRICS CORP reported the fourth quarter ended December 31, 2023 results: revenue $37.6 million.

Period: the fourth quarter ended December 31, 2023
Revenue: $37.6 million
Result: preliminary results

Exact text from the filing

Preliminary unaudited fourth quarter 2023 net revenue is expected to be $37.6 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ORTHOPEDIATRICS CORP reported the full year ended December 31, 2023 results: revenue $148.7 million.

Period: the full year ended December 31, 2023
Revenue: $148.7 million
Result: preliminary results

Exact text from the filing

Preliminary unaudited full year 2023 net revenue is expected to be $148.7 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ORTHOPEDIATRICS CORP reported the fiscal year ending December 31, 2024 results: revenue $197 million to $200 million. Guidance initiated.

Period: the fiscal year ending December 31, 2024
Revenue: $197 million to $200 million
Guidance: initiated
Result: guidance update

Exact text from the filing

OrthoPediatrics projects 2024 revenue to be in the range of $197 million to $200 million

View on SEC.gov

Browse all earnings releases →

ORTHOPEDIATRICS CORP filing history →

Source: SEC EDGAR

accession 0001425450-24-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.